|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-3.07/-2.97
|
企业价值
58.56M
|
资产负债 |
每股账面净值
-0.41
|
现金流量 |
现金流量率
--
|
损益表 |
收益
9.94M
|
每股收益
0.33
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/12/24 12:57 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. |